Bacterial otitis media: Current vaccine development strategies
- 1 February 2003
- journal article
- special feature
- Published by Wiley in Immunology & Cell Biology
- Vol. 81 (1) , 46-51
- https://doi.org/10.1046/j.0818-9641.2002.01141.x
Abstract
Otitis media is the most common reason for children less than 5 years of age to visit a medical practitioner. Whilst the disease rarely results in death, there is significant associated morbidity. The most common complication is loss of hearing at a critical stage of the development of speech, language and cognitive abilities in children.Keywords
This publication has 51 references indexed in Scilit:
- Development of hematogenous pneumococcal meningitis in adult mice: the role of TNF-αFEMS Immunology & Medical Microbiology, 2002
- Conservation of Outer Membrane Protein E among Strains of Moraxella catarrhalisInfection and Immunity, 2001
- Viral Co-Infection Does Not Reduce the Efficacy of Vaccination against Non-Typeable Haemophilus influenzae Middle Ear Infection in a Rat ModelORL, 2001
- The burden of otitis mediaVaccine, 2000
- Moraxella catarrhalis‐induced purulent otitis media in the rat middle earLAPMIS, 1999
- ACUTE OTITIS MEDIA IN CHILDRENPrimary Care: Clinics in Office Practice, 1996
- Respiratory virus infection as a cause of prolonged symptoms in acute otitis mediaThe Journal of Pediatrics, 1990
- Animal models of otitis mediaThe Pediatric Infectious Disease Journal, 1989
- The impact of otitis mediaThe Pediatric Infectious Disease Journal, 1989
- Identification of Respiratory Virus Antigens in Middle Ear Fluids of Children with Acute Otitis MediaThe Journal of Infectious Diseases, 1985